News
A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...
“Lung cancer is a disease where uncontrolled cell growth occurs in the lung leading to tumours,” explains Dr Jenny Messenger, ...
A recently-approved treatment could take a BiTE out of small cell lung cancer by using a person's own body to fight back.
SUPER sensitive cancer blood tests will be rolled out to NHS patients in a world first. People diagnosed with breast or lung ...
Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it ...
CAR T cell immunotherapy, which uses a patient's own modified immune cells to find and destroy cancer cells, can produce ...
Cambridge: AstraZeneca has announced that Imfinzi (durvalumab) has been recommended for approval in the European Union (EU) ...
Affinity Technologies, Inc. , a biotechnology company advancing noninvasive diagnostics and targeted therapeutics for cancer, today announced the U.S. Patent and Trademark Office (USPTO) has issued a ...
Ongoing research is focusing on combining cryoablation with immunotherapy to trigger stronger immune responses and redefine ...
3d
Zacks Investment Research on MSNAZN Gets CHMP Nod for Imfinzi in Muscle-Invasive Bladder CancerAstraZeneca AZN announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) rendered ...
A 56-year-old man presented for 3 weeks of intermittent blurred vision and photophobia.His medical history included type 2 diabetes, hypertension, hyperlipidemia, chronic obstructive pulmonary disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results